Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Adana
Clinical trial register · Turkey

Clinical Trials in Adana, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Ankara 101 Istanbul 81 Izmir 54 Adana 36 Antalya 31
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC42 AstraZeneca36 Cukurova University28 Eli Lilly and Company21 Hoffmann-La Roche16 Clear sponsor filter
Site location
Ankara101 Istanbul81 Izmir54 Adana36 Antalya31
All 57 locations
Target enrolment
to

Trials with a site in Adana

36 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Adana, Ankara, Antalya, Center, Istanbul, Izmir, Kahramanmaraş, Kütahya
2026-08-24
Recruiting
AstraZeneca
Phase 3
800
Adana, Ankara, Bursa, Izmir, Kayseri, Samsun
2026-07-06
Recruiting
AstraZeneca
Phase 3
900
Adana, Ankara, Antalya, Bakırköy, Gaziantep, Kayseri, Yüreğir
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Adana, Adapazarı, Ankara, Antalya, Istanbul
2026-06-29
Recruiting
AstraZeneca
Observational
2,150
Ankara, Adana, Gaziantep, Istanbul, Kayseri
2026-05-06
Active, closed
AstraZeneca
Phase 2
222
Adana, Adapazarı, Kahramanmaraş, Kayseri, Kocaeli
2025-12-05
Recruiting
AstraZeneca
Phase 2
435
Adana, Ankara, Diyarbakır, Istanbul, Mersin, Zeytinburnu
2025-11-06
Recruiting
AstraZeneca
Phase 2
987
Adana, Ankara, Bursa, İzmit, Kayseri, Mersin
2025-06-27
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Adana, Afyonkarahisar, Ankara, Izmir, İzmit
2025-06-10
Active, closed
AstraZeneca
Phase 3
3,103
Adana, Afyonkarahisar, Ankara, Eskişehir, Izmir, Kocaeli, Odunpazari, Yenimahalle
2025-05-28
Recruiting
AstraZeneca
Phase 2
540
Adana, Ankara, Bursa, Gaziantep, Istanbul, Kayseri, Mersin
2025-03-26
Recruiting
AstraZeneca
Phase 3
990
Adana, Ankara, Istanbul, Kayseri, Kocaeli, Mersin
2025-03-25
Recruiting
AstraZeneca
Phase 3
11,300
Adana, Afyonkarahisar, Ankara, Antalya, Eskişehir, Istanbul, Izmir, Kahramanmaraş
2025-03-14
Recruiting
AstraZeneca
Phase 3
5,000
Adana, Adapazarı, Altındağ, Ankara, Antalya, Haliliye, Kahramanmaraş, Kayseri
2025-03-03
Recruiting
AstraZeneca
Phase 3
3,850
Adana, Ankara, Antalya, Bursa, Center, Dinar, Eskişehir, Istanbul
2024-04-12
Active, closed
AstraZeneca
Phase 3
2,554
Adana, Adapazarı, Afyonkarahisar, Ankara, Antalya, Bursa, Istanbul, Kahramanmaraş
2024-03-29
Recruiting
AstraZeneca
Phase 3
5,250
Adana, Afyonkarahisar, Antalya, Bursa, Çanakkale, Çankaya, Isparta, Istanbul
2024-02-21
Recruiting
AstraZeneca
Phase 3
800
Adana, Ankara, Cordaleo, Istanbul
2023-09-22
Active, closed
AstraZeneca
Phase 3
1,350
Adana, Ankara, Edirne, Istanbul, Izmir
2022-12-29
Active, closed
AstraZeneca
Phase 3
341
Adana, Ankara, Edirne, Istanbul, Izmir
2022-08-03
Active, closed
AstraZeneca
Phase 3
1,035
Adana, Edirne, Izmir, Şahinbey, Yüreğir
2022-03-25
Active, closed
AstraZeneca
Phase 3
148
Adana, Ankara, Cordaleo, Edirne, Istanbul, Izmir, Kazımkarabekir
2021-10-28
Active, closed
AstraZeneca
Phase 3
712
Adana, Ankara, Antalya, Cordaleo, Edirne, Istanbul
2021-08-05
Active, closed
AstraZeneca
Phase 3
315
Adana, Ankara, Cordaleo, Izmir, Kadıkoy/Istanbul, Kayseri
2021-06-30
Active, closed
D9319C00001- 1L OC Mono Global RCT
NCT04884360Ovarian Cancer
DrugOlaparib
AstraZeneca
Phase 3
366
Adana, Ankara, Cordaleo, Istanbul, Samsun
2021-05-31
Active, closed
AstraZeneca
Phase 3
1,157
Adana, Ankara, Cordaleo, Malatya, Samsun
2021-04-26
Active, closed
AstraZeneca
Phase 1
155
Adana, Ankara, Istanbul, Izmir
2021-02-02
Active, closed
AstraZeneca
Phase 3
1,371
Adana, Ankara, Izmir, Kayseri
2021-01-28
Active, closed
AstraZeneca
Phase 3
957
Adana, Ankara, Erzurum, Istanbul, Samsun
2020-11-17
Active, closed
AstraZeneca
Phase 3
1,407
Adana, Ankara, Istanbul, Izmir
2019-01-04
Active, closed
AstraZeneca
Phase 3
407
Adana, Ankara, Edirne, Istanbul, Konya, Malatya
2018-11-27
Active, closed
AstraZeneca
Phase 3
895
Adana, Ankara, Cordaleo, Istanbul, Izmir
2018-10-31
Active, closed
AstraZeneca
Phase 3
730
Adana, Ankara, Antalya, Edirne, Istanbul, Izmir, Konya, Samsun
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Adana, Adapazarı, Ankara, Edirne, Istanbul, Izmir
2018-09-27
Active, closed
AstraZeneca
Phase 3
216
Adana, Adapazarı, Ankara, Istanbul, Izmir
2018-07-19
Active, closed
AstraZeneca
Phase 3
953
Adana, Ankara, Istanbul, Izmir
2015-11-03
Rows per page Showing 1–36 of 36
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/adana

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 36 of those studies with a site in Adana that also match the filters currently applied.

How many clinical trials are recruiting in Adana?

14 of the 36 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 22 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Adana), 36 studies
PhaseStudiesRecruitingShare
Phase 3301083.3%
Phase 24311.1%
Observational112.8%
Phase 1102.8%

Most active sponsors

Lead sponsors with the most studies (Adana)
Lead sponsorStudiesRecruiting
AstraZeneca3614
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.